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 There are two ageing processes, one physiological, also known as normal ageing, and that of pathological ageing, which 
depends on the occurrence of chronic diseases. The essence of the former is a gradual, progressive, and a very indivi-
dual restriction of the organs’ functional reserve with age. The changes occur in all cells, tissues and systems and do not 
affect each organ at the same time, and the rate of change can vary between organs. Therefore, the chronological age 
alone cannot be the factor determining the terapeutic decisions, including surgical treatment. Among the elderly, there 
is a distinct situation where acute stress response associated with surgery is imposed on the otherwise ageing-related, 
reduced physiological reserves and the cumulative effect of any accompanying diseases. Standard preparation for surgery 
and routine perioperative management in such patients can lead to serious complications. In older persons, even mini-
mal injury can exceed the body’s capacity to compensate, especially among those with frailty syndrome. It is critical to 
understand the physiological changes associated with ageing to better understand the differences in the management 
of these elderly patients.
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Surgery itself is aimed at removing the disease and is most 
often associated with partial or entire organ excision. In addi-
tion, it requires a number of invasive or potentially traumatic 
activities, such as insertion of cannulas into the vascular system, 
bladder catheterization, intubation, general anesthesia, etc. 
All of these lead to local tissue damage, disruption of natural 
barriers and exposure to external factors (physical, chemical 
and microbiological). This induces many changes in the body 
affecting the neuroendocrine, cytokine-immune, water-elec-
trolyte and metabolic systems. This, in turn, may be accompa-
nied by oxidative stress and the associated formation of free 
radicals [1]. Therefore, in the elderly, we have a particularly 
critical situation in which the acute stress responses associated 
with surgery are superimposed on the typical ageing-related 
decrease in physiological reserves (so-called normal ageing) 
and the cumulative effect of any accompanying diseases (so-
-called pathological ageing). Standard preparation for surgery 
and routine perioperative management in such patients is 
often insufficient and can lead to serious postoperative com-
plications. In older persons, even relatively minor injuries or 
trauma can exceed the body’s ability to compensate, which is 
especially the case for those with frailty syndrome. In order to 
better understand the difference in the management of these 
patients, it is important to be familiar with the physiological 
changes associated with the ageing process what will be 
presented in this part of the series.
The essence of so-called normal ageing is a gradual, 
progressive restriction of the functional reserve, which is the 
difference between the maximum organ function possible 
to achieve at a given moment of life and the bare minimum 
necessary to maintain homeostasis [2]. At present, the ageing 
process is irreversible and increases over time. However, the 
rate of decline in any given organ’s functional reserve varies 
between individuals and depends on each individual’s genetic 
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conditions and lifestyle. A reflection of the total depletion 
of functional reserves and adaptive capacity is the so-called 
“frailty syndrome”. It is characterized by organs and systems 
becoming “ineffective” in the event of a stress factor (surgery, 
infection, injury, etc.), resulting in an increased risk of adverse 
outcomes [3]. The details of the frailty syndrome are thoroughly 
presented in the first part of the series, in the previous issue of 
Nowotwory. Journal of Oncology [4].
In the case of normal ageing, a number of changes occur 
in all cells, tissues and systems. These changes do not affect 
each organ at the same time, and the rate of change can vary 
between organs.
Aging of the vascular system can affect both the heart 
and the vessels. Changes in the sinus node and other parts of 
the conduction system lead to the development of cardiac 
arrhythmias that may clinically manifest themselves through 
syncope and falls. These changes can also lead to a reduction 
in the maximum heart rate. In turn, the reduction of vagus ne-
rve tension and the reflex activity of the sympathetic nervous 
system may lead to an increase in resting heart rate. Within 
the myocardium, an increase in arterial stiffness results in com-
pensatory left ventricular hypertrophy. Progressive myocardial 
fibrosis reduces ventricular susceptibility and impairs filling 
during the contraction phase. Left ventricular contractility is 
also reduced. Together, this leads to a decrease in the left ven-
tricular ejection fraction and a reduction in exercise tolerance. 
In addition, vascular changes cause an increase in systolic 
blood pressure and a decrease in diastolic pressure, which 
have an adverse effect on coronary blood flow. Reduction of 
the diastolic capacity of precapillary arterioles has a negative 
effect on peripheral organ perfusion. Decrease in the sen-
sitivity of the baroreceptors increases the risk of orthostatic 
hypotension [5–7].
In the respiratory system, there are changes in the pul-
monary parenchyma, as well as the osteoarticular and mu-
scular system of the chest itself. Consequently, this results in 
a reduction in vital capacity, a reduction of forced expiratory 
volume in one second and a worsening of gas exchange in 
the lungs. The residual volume increases by up to 40%. Due 
to degenerative changes in the joints, ossification of the car-
tilaginous joints of the ribs and the decrease in the mass and 
strength of the respiratory muscles with age, chest mobility 
decreases and, as a result, so does pulmonary ventilation. The 
clinical manifestation is the acceleration of the breathing rate at 
rest and effort dyspnea. Reflex reactions in the upper respirato-
ry tract are weakened, which increases the risk of aspiration of 
gastrointestinal contents and postoperative pneumonia [8, 9].
Ageing of the digestive system is associated with redu-
ced secretion of saliva, gastric juice, bile and pancreatic juice. 
This leads to a worsening of protein and fat digestion, as well 
as disorders of iron absorption in the small intestine. The re-
duction in Castle’s intrinsic factor production is the reason for 
poor absorption of vitamin B12 and its overall deficiency. More 
than 70% of elderly people have lactose intolerance associated 
with the loss of lactase production by the brush border of 
the small intestine. Due to changes in diet, low fluid intake, 
use of diuretics and low physical activity, peristalsis slows 
and constipation occurs as a result. Liver mass and hepatic 
blood flow are reduced by 30%. The ability of hepatocytes to 
regenerate after an injury is likewise reduced. The intensity of 
metabolic processes is smaller, including those responsible for 
the metabolism of xenobiotics and drugs [9, 10].
From the fourth decade of life, the number of active ne-
phrons decreases in the renal system. Despite compensatory 
overgrowth of other active nephrons, renal blood flow and glo-
merular filtration rate are reduced by about 10 ml/min/1.73 m2/
decade and, after 65 years of age, 15 ml/min/1.73 m2/decade. 
The decrease in glomerular filtration rate is usually not ac-
companied by a parallel increase in serum creatinine due to 
a decrease in creatinine production as a result of decreased 
muscle mass with age. Due to the reduced elasticity of the 
bladder walls and weakness of the detrusor muscle, the vo-
lume of residual urine increases, which likewise increases the 
risk of urinary tract infection. Decreased activity of the renin-
-angiotensin system increases the risk of hyponatremia [11].
Ageing of the endocrine system is reflected by the 
extinction of gonadal hormonal function and a decrease in 
the secretion of growth hormone, dehydroepiandrostenedio-
ne, aldosterone, melatonin, thyroxine and insulin. This leads to 
osteoporosis and lipid and carbohydrate metabolic disorders, 
and also promotes hyponatremia. Secondary hyperparathy-
roidism is a commonly diagnosed disorder among elderly 
patients. It is most often caused by a vitamin D deficiency, 
which is associated with skin changes, lower exposure to solar 
radiation and a nutrient-deficient diet [12, 13].
Changes in the hematopoietic system lead to disorders 
in the normal formation of mature blood cells in the bone 
marrow. This process becomes more critical after the age 60, 
when the total number of active bone marrow cells decre-
ases by approximately 50% resulting in approximately 30% of 
the number of cells observed in youth. Erythropoiesis is the 
most affected, and further contributes to the development 
of anaemia in the elderly. The chemotactic, phagocytic and 
bactericidal activity of neutrophils and macrophages decrease, 
the proliferation of B and T lymphocytes in response to their 
stimulation decreases, which leads to an overall decrease in 
immunity, potentially more severe courses of infection, redu-
ced vaccine effectiveness and an increased risk of cancer [14].
With age, there is also a loss of muscle mass and strength, 
even in physically active people. Between the ages of 45 and 
85, an individual’s muscle mass is reduced by about 25%. It is 
estimated that a significant decrease in muscle mass affects 
40% of people over 80 years of age. Muscle strength decre-
ases at an even faster rate; after the age of 60, it is possible to 
lose up to 3% per year. Local accumulation of triglycerides 
and lipofuscin within muscle fibers and systemic metabolic 
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and hormonal disorders (insulin resistance and reduction of 
growth hormone and IGF-1), as well as ageing-related dege-
nerative changes of motor neurons, contribute to a decrease 
in muscle mass. The overall effect of muscle changes is not 
only a decrease in physical fitness, but also an increase in the 
risk of falls [2,15].
Progressive degenerative changes in the joints lead to 
a decrease in range of motion, which is often accompanied 
by pain. In the case of degenerative changes in the interver-
tebral cervical section, in addition to impaired blood flow in 
the vertebral arteries (cervico-basal syndrome), there may be 
neurological symptoms accompanying changes in the lumbar 
section. The effects of these changes include a change in po-
sture and gait and a decrease in general physical fitness [16,17].
Ageing also leads to significant changes in sensory or-
gans. Hardening of the lens nucleus leads to presbyopia, and 
a decrease in light transmission through the eye lens leads 
to deterioration of vision resolution, increased visual impa-
irment in the dark and difficulty distinguishing green-blue 
shades. A reduction in tear production leads to dry eye and 
an increased risk of conjunctival infection. Impaired reception 
of high-frequency tones can cause partial or total deafness. 
A person’s sense of smell may also be impaired due to a loss 
of nerve endings [18–21].
In the nervous system, the atrophy of hippocampal neu-
rons, reduction of neurotransmitter secretion and receptor 
density for neurotransmitters lead to reduced cognitive ability, 
increased risk of depression, prolonged reflex reaction time 
and a related increase in the risk of falls [22].
The aforementioned changes may be compounded by 
so-called pathological ageing, resulting from the impact 
of associated diseases on the previously described changes, 
which are characteristic of normal ageing. The result of this 
is seemingly disproportionate organ ageing. This process is 
most often caused by the adverse effects of lifestyle and envi-
ronmental factors, although it can also be caused, in some 
cases, by genetic background [2]. Vascular changes including 
macroangiopathy (atherosclerosis) and microangiopathy 
(diabetic microangiopathy) are of particular importance in 
cases like these. Impaired perfusion worsens the function of 
many organs, including the heart, brain, kidneys, intestines 
and skeletal muscles. It can also be a common cause of death 
associated with both heart attacks and strokes. Smoking, dust 
exposure and recurrent lower respiratory tract infections can 
lead to a faster reduction in lung function and pulmonary 
reserve. Obesity accelerates the course of degenerative joint 
processes and reduces the functional reserve of the heart 
and lungs, in addition to having adverse effects on metabolic 
Table I. Review of the organ changes associated with normal aging [2–25]
Vascular system Reduction in the maximum HR, increase in resting HR, compensatory left ventricular hypertrophy, reduced 
ventricular ejection fraction, increase in systolic blood pressure, decrease in diastolic pressure, reduction in the 
coronary blood flow and organ perfusion, decreased sensitivity of the baroreceptors.
Clinical manifestation: arrhythmias (leading to syncope and falls), reduced exercise tolerance, orthostatic 
hypotension. 
Respiratory system Reduction in VC, reduction in FEV1, worsening of gas exchange in the lungs, increased RV, reduced pulmonary 
ventilation, weakened reflex reactions in the upper respiratory tract. 
Clinical manifestation: acceleration of the breathing rate at rest and effort dyspnoea, increased risk of aspiration 
and postoperative pneumonia.
Digestive system Reduced secretion of saliva, gastric juice, bile and pancreatic juice, reduced peristalsis, reduced liver mass and 
hepatic blood flow, reduced regeneration of the hepatocytes after injury.
Clinical manifestation: worsened digestion of protein and fat, constipations, vitamin B12 deficiency, reduced 
metabolism of xenobiotics and drugs.
Renal system Reduction in the number of active nephrons decreases, decreased renal blood flow and glomerular filtration rate, 
reduced elasticity of the bladder walls and weakness of the detrusor muscle. 
Clinical manifestation: increase in the volume of residual urine increases the risk of infection.
Endocrine system Decrease in the secretion of growth hormone, dehydroepiandrostenedione, aldosterone, melatonin, thyroxine and 
insulin, vitamin D deficiency. 
Clinical manifestation: osteoporosis, lipid and carbohydrate metabolic disorders, increased risk of hyponatremia.
Hematopoietic system Decrease in active bone marrow cells (particularly erythropoiesis), decrease of the chemotactic, phagocytic and 
bactericidal activity of neutrophils and macrophages, decrease in the proliferation of B and T lymphocytes in 
response to their stimulation.
Clinical manifestation: anaemia, overall decrease in immunity, potentially more severe courses of infection, 
reduced vaccine effectiveness, increased risk of cancer.
Musculoskeletal changes Increased adiposity, reduced muscle mass, reduced grip strength, reduced body weight.
Clinical manifestation: decrease in physical fitness, increase in the risk of falls.
CNS and sensory organs Atrophy of hippocampal neurons, reduction of neurotransmitter secretion and receptor density for 
neurotransmitters.
Clinical manifestation: reduced cognitive ability, increased risk of depression, prolonged reflex reaction time, 
increase in the risk of falls.
Presbyopia, deterioration of vision resolution, difficulty in distinguishing green-blue shades, increased risk of 
conjunctival infection, partial or total deafness, deterioration of the smell. 
HR – hearth rate, VC– vital capacity, FEV1 – forced expiratory volume in one second, RV – residual volume
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processes, including those associated with an increase in the 
risk of type 2 diabetes. Exposure to loud noises accelerates 
the ageing and degradation of the hearing organ. Exposure 
to ultraviolet radiation accelerates skin ageing. Exposure to 
ionizing and infrared radiation accelerates the development 
of cataracts. Hard physical work and injuries likewise accelerate 
the degeneration of joints [23, 24]. 
The effect of postoperative stress is more detrimental to 
some organs than others. Therefore, the leading causes of 
postoperative mortality among the elderly are: myocardial in-
fraction, pulmonary and cerebrovascular complications [2, 25]. 
Therefore, preoperative comprehensive geriatric assessment of 
organ function and reserves should be obligatory in the older 
population, particularly undergoing cancer surgery.
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